BCAP31P2

Across TCGA pan-cancer cohorts, BCAP31P2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated BCAP31P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher BCAP31P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BCAP31P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

KIRC, KIRP, and BRCA are the cancer types where BCAP31P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.307	0.566	.002	43	view →
KIRP	DFS	Median	All	0.749	0.978	<.001	37	view →
BRCA	OS	Median	IV	0.335	0.761	.004	33	view →
HNSC	DFS	Quartile	IV	0.768	0.586	.006	32	view →
LGG	OS	Tertile	All	0.815	0.921	.001	22	view →
MESO	OS	Tertile	IV	0.240	0.692	.008	15	view →
SKCM	OS	Median	III,IV	0.586	0.291	.011	11	view →
PCPG	DFS	Quartile	All	0.763	0.959	.006	11	view →
STAD	DFS	Tertile	II,III,IV	0.770	0.574	.015	9	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	5	view →
SARC	OS	Median	All	0.683	0.780	.018	5	view →
COAD	DFS	Median	All	0.432	0.571	.036	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

BCAP31P2–KIRC (DFS)

Open the KIRC breakdown →